Revealing the molecular mechanism of colorectal cancer by establishing LGALS3-related protein-protein interaction network and identifying signaling pathways

International Journal of Molecular Medicine

Volumn 33, Issue 3, 2014, Pages 581-588

  Han, Lu ^a   Wu, Zhixiong ^b   Zhao, Qicheng ^b,c  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b Chongqing Cancer Institute   (China)

^c TONGJI UNIVERSITY   (China)

Author keywords

Colorectal cancer; Differentially expressed genes; Gene ontology analysis; Protein protein interaction network; Signaling pathway

Indexed keywords

COLORECTAL NEOPLASMS; GALECTIN 3; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN INTERACTION MAPS; SIGNAL TRANSDUCTION;

EID: 84893867170     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1620     Document Type: Article

References (47)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Atkin WS, Edwards R, Kralj-Hans I, et al: Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: A multicentre randomised controlled trial. Lancet 375: 1624-1633, 2010.
3. Grady WM and Carethers JM: Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 135: 1079-1099, 2008.
4. Leggett B and Whitehall V: Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 138: 2088-2100, 2010.
5. Stratton MR, Campbell PJ and Futreal PA: The cancer genome. Nature 458: 719-724, 2009.
6. Lanza G, Ferracin M, Gafa R, et al: MRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Mol Cancer 6: 54, 2007.
7. Jones S, Zhang X, Parsons DW, et al: Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321: 1801-1806, 2008.
8. Lustig B and Behrens J: The Wnt signaling pathway and its role in tumor development. J Cancer Res Clin Oncol 129: 199-221, 2003.
9. Maxwell PH, Pugh CW and Ratcliffe PJ: Activation of the HIF pathway in cancer. Curr Opin Genet Dev 11: 293-299, 2001.
10. Sankpal UT, Goodison S, Abdelrahim M and Basha R: Targeting SP1 transcription factor in prostate cancer therapy. Med Chem 7: 518-525, 2011.
11. Tomlins SA, Rhodes DR, Perner S, et al: Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310: 644-648, 2005.
12. Yang Y, Goldstein BG, Chao HH and Katz JP: KLF4 and KLF5 regulate proliferation, apoptosis and invasion in esophageal cancer cells. Cancer Biol Ther 4: 1216-1221, 2005.
13. Dolcet X, Llobet D, Pallares J and Matias-Guiu X: NF-?B in development and progression of human cancer. Virchows Arch 446: 475-482, 2005.
14. Sabates-Bellver J, Van Der Flier LG, De Palo M, et al: Transcriptome profile of human colorectal adenomas. Mol Cancer Res 5: 1263-1275, 2007.
15. Bresalier RS, Mazurek N, Sternberg LR, et al: Metastasis of human colon cancer is altered by modifying expression of the β-galactoside-binding protein galectin 3. Gastroenterology 115: 287-296, 1998.
16. Zhao Q, Guo X, Nash GB, et al: Circulating galectin-3 promotes metastasis by modifying MUC1 localization on cancer cell surface. Cancer Res 69: 6799-6806, 2009.
17. Zhao Q, Barclay M, Hilkens J, et al: Research interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis. Mol Cancer 9: 154, 2010.
18. Irizarry RA, Hobbs B, Collin F, et al: Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264, 2003.
19. Tusher VG, Tibshirani R and Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121, 2001.
20. Harris M, Clark J, Ireland A, et al: The gene ontology (GO) database and informatics resource. Nucleic Acids Res 32: D258-D261, 2004.
21. Huang da W, Sherman BT and Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinfor-matics resources. Nat Protoc 4: 44-57, 2008.
22. Tarca AL, Draghici S, Khatri P, et al: A novel signaling pathway impact analysis. Bioinformatics 25: 75-82, 2009.
23. Essaghir A, Toffalini F, Knoops L, Kallin A, van Helden J and Demoulin JB: Transcription factor regulation can be accu-rately predicted from the presence of target gene signatures in microarray gene expression data. Nucleic Acids Res 38: E120, 2010.
24. von Mering C, Huynen M, Jaeggi D, Schmidt S, Bork P and Snel B: STRING: A database of predicted functional associations between proteins. Nucleic Acids Res 31: 258-261, 2003.
25. Kohl M, Wiese S and Warscheid B: Cytoscape: Software for visualization and analysis of biological networks. In: Data Mining in Proteomics. Hamacher M Eisenacher M and Stephan C (eds.). Humana Press. pp291-303, 2011.
26. Steeg PS: Tumor metastasis: Mechanistic insights and clinical challenges. Nat Med 12: 895-904, 2006.
27. Cox DG, Hankinson SE and Hunter DJ: Polymorphisms of the AURKA (STK15/Aurora Kinase) gene and breast cancer risk (United States). Cancer Causes Control 17: 81-83, 2006.
28. Couch FJ, Sinilnikova O, Vierkant RA, et al: AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: A consortium of investigators of modifiers of BRCA1/2 study. Cancer Epidemiol Biomarkers Prev 16: 1416-1421, 2007.
29. Zhu X, Mao Z, Na Y, Guo Y, Wang X and Xin D: Significance of pituitary tumor transforming gene 1 (PTTG1) in prostate cancer. Anticancer Res 26: 1253-1259, 2006.
30. Gorynia S, Bandeiras TM, Pinho FG, et al: Structural and functional insights into a dodecameric molecular machine-the RuvBL1/RuvBL2 complex. J Struct Biol 176: 279-291, 2011.
31. Carattino MD, Prakasam HS, Ruiz WG, et al: Bladder filling and voiding affect umbrella cell tight junction organization and function. Am J Physiol Renal Physiol: Jul 24, 2013 (Epub ahead of print).
32. Osunkoya AO, Cohen C, Lawson D, Picken MM, Amin MB and Young AN: Claudin-7 and claudin-8: Immunohistochemical markers for the differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma. Hum Pathol 40: 206-210, 2009.
33. Katoh M and Katoh M: CLDN23 gene, frequently down-regulated in intestinal-type gastric cancer, is a novel member of CLAUDIN gene family. Int J Mol Med 11: 683-689, 2003.
34. Vogelstein B and Kinzler KW: Cancer genes and the pathways they control. Nat Med 10: 789-799, 2004.
35. Malumbres M and Barbacid M: Cell cycle, CDKs and cancer: A changing paradigm. Nat Rev Cancer 9: 153-166, 2009.
36. Sherr CJ: Cancer cell cycles. Science 274: 1672-1677, 1996.
37. Maruyama K, Kawagoe T, Kondo T, Akira S and Takeuchi O: TRAF family member-associated NF-?B activator (TANK) is a negative regulator of osteoclastogenesis and bone formation. J Biol Chem 287: 29114-29124, 2012.
38. O'neill LA and Kaltschmidt C: NF-?B: A crucial transcription factor for glial and neuronal cell function. Trends Neurosci 20: 252-258, 1997.
39. Barnes PJ: Nuclear factor-?B. Int J Biochem Cell Biol 29: 867-870, 1997.
40. Scartozzi M, Bearzi I, Pierantoni C, et al: Nuclear factor-?B tumor expression predicts response and survival in irinotecan-refractory metastatic colorectal cancer treated with cetuximab-irinotecan therapy. J Clin Oncol 25: 3930-3935, 2007.
41. Darnell JE Jr: Transcription factors as targets for cancer therapy. Nat Rev Cancer 2: 740-749, 2002.
42. Bièche I, Laurendeau I, Tozlu S, et al: Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay. Cancer Res 59: 2759-2765, 1999.
43. Le Floch N, Rivat C, De Wever O, et al: The proinvasive activity of Wnt-2 is mediated through a noncanonical Wnt pathway coupled to GSK-3β and c-Jun/AP-1 signaling. FASEB J 19: 144-146, 2005.
44. Kojima T, Shimazui T, Horie R, et al: FOXO1 and TCF7L2 genes involved in metastasis and poor prognosis in clear cell renal cell carcinoma. Genes Chromosomes Cancer 49: 379-389, 2010.
45. Arden KC: Multiple roles of FOXO transcription factors in mammalian cells point to multiple roles in cancer. Exp Gerontol 41: 709-717, 2006.
46. Roy S, Srivastava R and Shankar S: Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer. J Mol Signal 5: 10, 2010.
47. John A and Tuszynski G: The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 7: 14-23, 2001.